​

SCYNEXIS (SCYX) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChart

SCYX Stock Rating

SCYNEXIS stock's rating consensus is Buy, based on 13 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 13 Buy (100.00%), 0 Hold (0.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 13 0 13 Strong Sell Sell Hold Buy Strong Buy

SCYX Price Target Upside V Benchmarks

TypeNameUpside
StockSCYNEXIS-
SectorHealthcare Stocks 23.68%
IndustrySpecialty & Generic Drug Manufacturers Stocks28.78%

Price Target Trends

1M3M12M
# Anlaysts---
Avg Price Target---
Last Closing Price$0.82$0.82$0.82
Upside/Downside---
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jun, 2512---3
May, 2512---3
Apr, 2512---3
Mar, 2512---3
Feb, 2512---3
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Mar 01, 2023GuggenheimBuyinitialise

Financial Forecast

EPS Forecast

$-3 $-2 $-1 $0 $1 $2 $3 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-1.25$-1.47$1.40$-0.44----
Avg Forecast$-1.00$-1.41$1.59$-0.43$0.37$1.47$0.12$0.15
High Forecast$-0.54$-0.68$1.86$-0.19$0.58$2.60$0.51$0.24
Low Forecast$-1.97$-2.78$1.33$-0.68$0.16$0.88$-0.09$0.07
Surprise %25.00%4.26%-11.95%2.33%----

Revenue Forecast

$0 $50M $100M $150M $200M $250M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$13.16M$5.09M$140.14M$3.75M----
Avg Forecast$11.80M$4.71M$141.89M$12.96M$60.27M$127.42M$52.60M$55.76M
High Forecast$20.64M$8.24M$203.30M$18.57M$86.35M$127.42M$52.60M$79.89M
Low Forecast$7.68M$2.83M$80.48M$7.35M$34.19M$127.42M$52.60M$31.63M
Surprise %11.57%8.09%-1.23%-71.09%----

Net Income Forecast

$-150M $-90M $-30M $30M $90M $150M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-32.87M$-62.81M$67.04M$-21.29M----
Avg Forecast$-48.23M$-68.11M$67.04M$-20.97M$20.10M$81.62M$4.94M$7.42M
High Forecast$-26.33M$-32.84M$89.91M$-9.17M$28.23M$125.82M$24.68M$11.59M
Low Forecast$-95.24M$-134.54M$64.22M$-32.77M$7.90M$42.58M$-4.36M$3.25M
Surprise %-31.85%-7.78%-1.52%----

SCYX Forecast FAQ

Is SCYNEXIS stock a buy?

SCYNEXIS stock has a consensus rating of Buy, based on 13 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 13 Buy, 0 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that SCYNEXIS is a favorable investment for most analysts.

What is SCYNEXIS's price target?

SCYNEXIS's price target, set by 13 Wall Street analysts, averages - over the next 12 months. The price target range spans from - at the low end to - at the high end, suggesting a potential 0% change from the previous closing price of $0.82.

How does SCYNEXIS stock forecast compare to its benchmarks?

SCYNEXIS's stock forecast shows a 0% downside, underperforming the average forecast for the healthcare stocks sector (23.68%) and underperforming the specialty & generic drug manufacturers stocks industry (28.78%).

What is the breakdown of analyst ratings for SCYNEXIS over the past three months?

  • June 2025: 33.33% Strong Buy, 66.67% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • May 2025: 33.33% Strong Buy, 66.67% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • April 2025: 33.33% Strong Buy, 66.67% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is SCYNEXIS’s EPS forecast?

SCYNEXIS's average annual EPS forecast for its fiscal year ending in December 2025 is $0.37, marking a -184.09% decrease from the reported $-0.44 in 2024. Estimates for the following years are $1.47 in 2026, $0.12 in 2027, and $0.15 in 2028.

What is SCYNEXIS’s revenue forecast?

SCYNEXIS's average annual revenue forecast for its fiscal year ending in December 2025 is $60.27M, reflecting a 1508.84% increase from the reported $3.75M in 2024. The forecast for 2026 is $127.42M, followed by $52.6M for 2027, and $55.76M for 2028.

What is SCYNEXIS’s net income forecast?

SCYNEXIS's net income forecast for the fiscal year ending in December 2025 stands at $20.1M, representing a -194.44% decrease from the reported $-21.288M in 2024. Projections indicate $81.62M in 2026, $4.94M in 2027, and $7.42M in 2028.